Literature DB >> 21904891

The effect of poly sterilization on wear, osteolysis and survivorship of a press-fit cup at 10-year followup.

Charles A Engh1, Cara C Powers, Henry Ho, Sarah E Beykirch-Padgett, Robert H Hopper, C Anderson Engh.   

Abstract

BACKGROUND: During the mid-1990s when our institution was using a press-fit porous-coated cup without supplemental initial fixation for primary THA, the manufacturer transitioned from gamma irradiation to gas plasma for the terminal sterilization of their polyethylene liners. QUESTIONS/PURPOSES: At minimum 10-year followup, we asked whether the fixation achieved by solely relying on a press-fit would be durable and how different liner sterilization methods affected radiographic wear, osteolysis, and survivorship. PATIENTS AND METHODS: We retrospectively reviewed 373 patients who underwent 398 primary THAs with a press-fit porous-coated cup between March 1995 and December 1996. Mean age at time of surgery was 61.5 ± 13.3 years and mean followup was 10.4 ± 3.7 years. We determined reasons for revision, survivorship, femoral head penetration, osteolysis, and wear-related complications.
RESULTS: Among 20 revisions involving any component, seven were associated with wear and osteolysis. Kaplan-Meier survivorship, using component revision for any reason as an end point, was 95.7% (95% confidence interval, 93.6%-97.9%) at 10 years. Noncrosslinked liners sterilized with gas plasma demonstrated a mean head penetration rate of 0.20 ± 0.09 mm/year compared with 0.13 ± 0.07 mm/year for liners sterilized with gamma irradiation in air and 0.09 ± 0.04 mm/year for liners sterilized with gamma-irradiation with barrier packaging without oxygen. THAs with increased volumetric wear tended to demonstrate larger osteolytic lesions (r = 0.40) and there tended to be less osteolysis among the liners sterilized with gamma-irradiation with barrier packaging without oxygen. However, there was no difference in survivorship among the sterilization groups and there has been no cup or stem loosening associated with osteolysis.
CONCLUSIONS: Durable biologic fixation through 10-year followup can be achieved by solely relying on an initial press-fit. Noncrosslinking gas plasma for terminal sterilization of the polyethylene liners was associated with greater head penetration rate than gamma irradiation. LEVEL OF EVIDENCE: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21904891      PMCID: PMC3254762          DOI: 10.1007/s11999-011-2052-2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  42 in total

1.  Migration of the Duraloc cup at two years.

Authors:  B Stöckl; M Sandow; M Krismer; R Biedermann; C Wimmer; B Frischhut
Journal:  J Bone Joint Surg Br       Date:  1999-01

2.  Press fit fixation of cementless cups: how much stability do we need indeed?

Authors:  A Roth; T Winzer; K Sander; J O Anders; R-A Venbrocks
Journal:  Arch Orthop Trauma Surg       Date:  2006-01-27       Impact factor: 3.067

3.  Second-generation porous-coated cementless total hip arthroplasties have high survival.

Authors:  Christopher J Chen; John S Xenos; James P McAuley; Anthony Young; Charles A Engh
Journal:  Clin Orthop Relat Res       Date:  2006-10       Impact factor: 4.176

4.  Determination of polyethylene wear in total hip replacements with use of digital radiographs.

Authors:  J M Martell; S Berdia
Journal:  J Bone Joint Surg Am       Date:  1997-11       Impact factor: 5.284

5.  Long-term durability of cemented primary total hip arthroplasty.

Authors:  R M Kay; F J Dorey; K Johnston-Jones; A Cracchiolo; H C Amstutz; G A Finerman
Journal:  J Arthroplasty       Date:  1995-11       Impact factor: 4.757

6.  The effect of total hip arthroplasty cup design on polyethylene wear rate.

Authors:  William G Hamilton; Robert H Hopper; Stuart D Ginn; Neil P Hammell; C Anderson Engh; Charles A Engh
Journal:  J Arthroplasty       Date:  2005-10       Impact factor: 4.757

7.  Characteristics of pelvic osteolysis on computed tomography after total hip arthroplasty.

Authors:  Nobuto Kitamura; Serena B Leung; Charles A Engh
Journal:  Clin Orthop Relat Res       Date:  2005-12       Impact factor: 4.176

8.  Long-term outcome of a cementless, hemispherical, press-fit acetabular component: survivorship analysis and dose-response relationship to linear polyethylene wear.

Authors:  N W Emms; I Stockley; A J Hamer; J M Wilkinson
Journal:  J Bone Joint Surg Br       Date:  2010-06

9.  The pros and cons of polyethylene sterilization with gamma irradiation.

Authors:  Robert H Hopper; C Anderson Engh; LaTonya B Fowlkes; Charles A Engh
Journal:  Clin Orthop Relat Res       Date:  2004-12       Impact factor: 4.176

10.  Oxidation and oxidation potential in contemporary packaging for polyethylene total joint replacement components.

Authors:  Luigi Costa; Pierangiola Bracco; Elena Maria Brach del Prever; Steven M Kurtz; Paolo Gallinaro
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2006-07       Impact factor: 3.368

View more
  4 in total

1.  Total hip arthroplasty at the rothman institute.

Authors:  Matthew S Austin; Carlos A Higuera; Richard H Rothman
Journal:  HSS J       Date:  2012-04-17

2.  Dual offset metaphyseal-filling stems in primary total hip arthroplasty in dysplastic hips after a minimum follow-up of ten years.

Authors:  Goksel Dikmen; Vahit Emre Ozden; Burak Beksac; Ismail Remzi Tozun
Journal:  Int Orthop       Date:  2018-09-19       Impact factor: 3.075

3.  Bearing surfaces in primary total hip arthroplasty.

Authors:  Luigi Zagra; Enrico Gallazzi
Journal:  EFORT Open Rev       Date:  2018-05-21

4.  The use of acetabular screws in total hip arthroplasty and its influence on wear and periacetabular osteolysis in the long-term follow-up.

Authors:  Steffen Brodt; Kathleen Bischoff; Marcel Schulze; Dimitri Nowack; Andreas Roth; Georg Matziolis
Journal:  Int Orthop       Date:  2021-09-28       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.